Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 6258-6264, November 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thampoe, I. J.
Right arrow Articles by Lloyd, K. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thampoe, I. J.
Right arrow Articles by Lloyd, K. O.

Sialyltransferase Levels and Ganglioside Expression in Melanoma and Other Cultured Human Cancer Cells1

Immac J. Thampoe, Koichi Furukawa, Eugenia Vellvé and Kenneth O. Lloyd

Memorial Sloan-Kettering Cancer Center, New York, NY 10021

Human melanoma cells express high levels of GM3 and GD3 gangliosides whereas normal melanocytes have only low levels of GD3 but maintain their expression of GM3. In order to understand the basis for this difference, the levels of the sialyltransferase that converts GM3 to GD3 (CMP-N-acetylneuraminic acid:GM3 sialyltransferase or GD3 synthase, EC 2.4.99.8) were analyzed in melanoma and other cell lines. Enzyme levels were determined in vitro using membrane preparations and measuring the addition of [14C]-N-acetylneuraminic acid from CMP-[14C]-N-acetylneuraminic acid to GM3 in the presence of Triton CF-54. Sialyltransferase levels in 44 human cancer cell lines (including melanoma, neuroblastoma, astrocytoma, various carcinomas, and leukemias) and cultures of normal melanocytes and kidney epithelial cells were compared, and the products were identified by thin layer chromatography and fluorography. Melanoma cell lines exhibited the highest levels of incorporation and GD3 was found to be the major product. GM3 was also formed, apparently from endogenous lactosylceramide. Very low levels of GD3 synthase were found in normal melanocytes. Neuroblastoma and some astrocytoma cell lines also had significant levels of GD3 synthase. Some other cell lines incorporated high levels of radioactivity but the products did not correspond to GD3 and the major product was usually GM3. In general the levels of GD3 synthase correlated with the expression of GD3 in the various cell types. These results point to higher levels of GD3 synthase being directly responsible for the enhanced expression of GD3 in melanoma.

1 This work was supported in part by National Cancer Institute Grants CA-08478 and CA-21445.

Received 2/ 3/89. Revised 7/17/89. Accepted 8/22/89.




This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
H.-M. Dae, H.-Y. Kwon, N.-Y. Kang, N.-R. Song, K.-S. Kim, C.-H. Kim, J.-H. Lee, and Y.-C. Lee
Isolation and functional analysis of the human glioblastoma-specific promoter region of the human GD3 synthase (hST8Sia I) gene
Acta Biochim Biophys Sin, March 1, 2009; 41(3): 237 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Nakamura, N. Haines, J. Chen, T. Okajima, K. Furukawa, T. Urano, P. Stanley, K. D. Irvine, and K. Furukawa
Identification of a Drosophila Gene Encoding Xylosylprotein beta 4-Galactosyltransferase That Is Essential for the Synthesis of Glycosaminoglycans and for Morphogenesis
J. Biol. Chem., November 22, 2002; 277(48): 46280 - 46288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Fukumoto, T. Mutoh, T. Hasegawa, H. Miyazaki, M. Okada, G. Goto, K. Furukawa, T. Urano, and K. Furukawa
GD3 Synthase Gene Expression in PC12 Cells Results in the Continuous Activation of TrkA and ERK1/2 and Enhanced Proliferation
J. Biol. Chem., February 25, 2000; 275(8): 5832 - 5838.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Okajima, K. Yoshida, T. Kondo, and K. Furukawa
Human Homolog of Caenorhabditis elegans sqv-3 Gene Is Galactosyltransferase I Involved in the Biosynthesis of the Glycosaminoglycan-Protein Linkage Region of Proteoglycans
J. Biol. Chem., August 13, 1999; 274(33): 22915 - 22918.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Okajima, S. Fukumoto, H. Miyazaki, H. Ishida, M. Kiso, K. Furukawa, T. Urano, and K. Furukawa
Molecular Cloning of a Novel {alpha}2,3-Sialyltransferase (ST3Gal VI) That Sialylates Type II Lactosamine Structures on Glycoproteins and Glycolipids
J. Biol. Chem., April 23, 1999; 274(17): 11479 - 11486.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yamashiro, M. Haraguchi, K. Furukawa, K. Takamiya, A. Yamamoto, Y. Nagata, K. O. Lloyd, H. Shiku, and K. Furukawa
Substrate Specificity of beta1,4-N-Acetylgalactosaminyltransferase in Vitro and in cDNA-transfected Cells
J. Biol. Chem., March 17, 1995; 270(11): 6149 - 6155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.